Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Candel Therapeutics, Inc. | 154,000 | reported | 26 Jan 2026 | tx 20+645,911−197,324 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Jan 2026 | GRANT_AWARD | Candel Therapeutics, Inc. | 154,000 | 0.00 USD | deriv |
| 25 Jun 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 5,353 | 4.67 USD | |
| 17 Mar 2025 | SALE | Candel Therapeutics, Inc. | 31,278 | 8.82 USD | |
| 17 Mar 2025 | EXERCISE | Candel Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 12 Feb 2025 | GRANT_AWARD | Candel Therapeutics, Inc. | 65,000 | 0.00 USD | deriv |
| 15 Jan 2025 | SALE | Candel Therapeutics, Inc. | 14,322 | 7.23 USD | |
| 08 Jan 2025 | SALE | Candel Therapeutics, Inc. | 14,545 | 8.22 USD | |
| 29 Nov 2024 | SALE | Candel Therapeutics, Inc. | 20,392 | 4.56 USD | |
| 17 Jul 2024 | SALE | Candel Therapeutics, Inc. | 14,851 | 6.47 USD | |
| 11 Jul 2024 | SALE | Candel Therapeutics, Inc. | 13,330 | 5.97 USD | |
| 28 Nov 2023 | TAX_WITHHOLDING | Candel Therapeutics, Inc. | 17,328 | 0.90 USD | |
| 26 Nov 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 104,516 | 0.00 USD | |
| 28 Apr 2023 | GRANT_AWARD | Candel Therapeutics, Inc. | 90,000 | 0.00 USD | deriv |
| 09 Dec 2022 | PURCHASE | Candel Therapeutics, Inc. | 10,358 | 1.93 USD | |
| 08 Dec 2022 | PURCHASE | Candel Therapeutics, Inc. | 3,000 | 1.69 USD | |
| 28 Nov 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 73,684 | 0.00 USD | |
| 14 Apr 2022 | GRANT_AWARD | Candel Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |